A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment

Psychopharmacology

Volumn 215, Issue 3, 2011, Pages 549-566

  Klinkenberg, Inge ^a   Blokland, Arjan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acetylcholine; Animal model; Attention; Delayed nonmatching to position; Fixed ratio; Memory; Motivation; Muscarinic; Progressive ratio; Sensorimotor

Indexed keywords

BIPERIDEN; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; MUSCARINIC M1 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; FOOD INTAKE; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SENSORIMOTOR FUNCTION; SHORT TERM MEMORY; STIMULUS RESPONSE; TASK PERFORMANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; MEMORY; PATHOPHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BIPERIDEN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMORY; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; REINFORCEMENT SCHEDULE; SCOPOLAMINE; TIME FACTORS;

EID: 79960793767     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2171-1     Document Type: Article

References (122)

1. Andrews JS, Grützner M, Stephens DN (1992) Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats. Psychopharmacology 106: 523-530
2. Andrews JS, Jansen JHM, Linders S, Princen A (1994) Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology 115: 485-494 (Pubitemid 24248439)
3. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, Seki K, Itohara S, Kawano M, Tanemura K, Takashima A, Yamada K, Kondoh Y, Kanno I, Wess J, Yamada M (2006) Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 24: 334-344 (Pubitemid 44572752)
4. Aura J, Sirviö J, Riekkinen P (1997) Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test. Eur J Pharmacol 333: 129-134 (Pubitemid 27387382)
5. Barak S, Weiner I (2009) Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. Int J Neuropsychopharmacol 12: 227-241
6. Bartholomeo AC, Morris H, Buccafusco JJ, Kille N, Rosenzweig-Lipson S, Husbands MG, Sabb AL, Abou-Gharbia M, Moyer JA, Boast CA (2000) The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist. J Pharmacol Exp Ther 292: 584-596 (Pubitemid 30067421)
7. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417 (Pubitemid 12048290)
8. Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21: 285-300 (Pubitemid 26188014)
9. Blokland A, Şik A, Van Der Staay FJ (2004) Delayed non-matching to position performance in aged hybrid Fischer 344×Brown Norway rats: a longitudinal study. Brain Res Bull 64: 39-46 (Pubitemid 38953467)
10. Boddeke EWGM, Enz A, Shapiro G (1992) SDZ ENS 163, a selective muscarinic M1 receptor agonist, facilitates the induction of longterm potentiation in rat hippocampal slices. Eur J Pharmacol 222: 21-25
11. Bolden C, Cusack B, Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260: 576-580
12. Broersen LM, Heinsbroek RPW, de Bruin JPC, Joosten RNJ, van Hest A, Olivier B (1994) Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade. Brain Res 645: 113-122 (Pubitemid 24140117)
13. Broersen LM, Heinsbroek RPW, de Bruin JPC, Uylings HBM, Olivier B (1995) The role of the medial prefrontal cortex of rats in shortterm memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 674: 221-229
14. Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE (2008) The scopolamine-reversal paradigm in rats and monkeys: the importance of computerassisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology 199: 481-494 (Pubitemid 351938233)
15. Burgard EC, Sarvey JM (1990) Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neurosci Lett 116: 34-39 (Pubitemid 20237132)
16. Bushnell PJ, Oshiro WM, Padnos BK (1997) Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology 134: 230-241 (Pubitemid 27520977)
17. Bymaster FP, Heath I, Hendrix JC, Shannon HE (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 267: 16-24 (Pubitemid 23324983)
18. Bymaster FP, McKinzie DL, Felder CC, Wess J (2003) Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res 28: 437-442 (Pubitemid 36314830)
19. Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (1998) Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur J Neurosci 10: 2887-2895 (Pubitemid 29073961)
20. Calabresi P, Centonze D, Gubbellini P, Bernardi G (1999) Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology 38: 323-326 (Pubitemid 29073555)
21. Callahan MJ, Kinsora JJ, Harbaugh RE, Reeder TM, Davis RE (1993) Continuous icv infusion of scopolamine impairs sustained attention of rhesus monkeys. Neurobiol Aging 14: 147-151 (Pubitemid 23103766)
22. Carey GJ, Billard W, Binch H, Cohen-Williams M, Crosby G, Grzelak M, Guzik H, Kozlowksi JA, Lowe DB, Pond AJ, Tedesco RP, Watkins RW, Coffin VL (2001) SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431: 189-200 (Pubitemid 33132125)
23. Caulfield MP (1993) Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 58: 319-379
24. Caulfield MP, Birdsall NJM (1998) International union of pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290 (Pubitemid 28304029)
25. Cheal ML (1981) Scopolamine disrupts maintenance of attention rather than memory processes. Behav Neural Biol 33: 163-187 (Pubitemid 12217677)
26. Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Cell 30: 148-155
27. Cunha GMA, Canas PM, Melo CS, Hockemeyer J, Müller CE (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801. Exp Neur 210: 776-781
28. Dai Y, Ambudkar IS, Horn VJ, Yeh C, Kousvelari EE, Wall SJ, Li M, Yasuda RP, Wolfe BB, Baum BJ (1991) Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am J Physiol 261: C1063-C1073
29. Daniel JM, Dohanich GP (2001) Acetylcholine mediates the estrogeninduced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J Neurosci 21: 6949-6956 (Pubitemid 32781137)
30. De Klippel N, Sarre S, Ebinger G, Michotte Y (1993) Effect of M1-and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res 630: 57-64 (Pubitemid 23342826)
31. Doralp S, Leung LS (2008) Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation. Neurobiol Learn Mem 90: 382-388
32. Doty RL, Bagla R, Misra R, Mueller E, Kerr K (2003) No influence of scopolamine hydrobromide on odor detection performance of rats. Chem Senses 28: 761-765 (Pubitemid 39144869)
33. Drinkenburg WHIM, Sondag HNPM, Coenders CJH, Andrews JS, Vossen JMH (1995) Effects of selective antagonism or depletion of the cholinergic system on visual discrimination performance in rats. Behav Pharmacol 6: 695-702
34. Dunnett SB, Wareham AT, Torres EM (1990) Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. NeuroReport 1: 61-64
35. Estape N, Steckler T (2002) Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of mice. Pharmacol Biochem Behav 72: 319-334 (Pubitemid 34251342)
36. Evans HL (1975) Scopolamine effects on visual discrimination: modifications related to stimulus control. J Pharmacol Exp Ther 195: 105-113
37. Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48: 649-684 (Pubitemid 127485189)
38. Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14: 220-223
39. Flynn DD, Reever CM, Ferrari-DiLeo G (1997) Pharmacological strategies to selectively label and localize muscarinic receptor subtypes. Drug Dev Res 40: 104-116 (Pubitemid 27281619)
40. Fornari RV, Moreira KM, Oliviera MGM (2000) Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem 7: 287-292
41. Forster GL, Yeomans JS, Takeuchi J, Blaha CD (2001) M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 21: 1-6
42. Frey KA, Ehrenkaufer RL, Agranoff BW (1985) Quantitative in vivo receptor binding. II. Autoradiographic imaging of muscarinic cholinergic receptors. J Neurosci 5: 2407-2414 (Pubitemid 15226932)
43. Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S (2001) Hyperactivity, elevated dopaminergic transmission and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. P Natl Acad Sci 98: 15312-15317 (Pubitemid 34014011)
44. Granon S, Poucet B (1995) Medial prefrontal lesions in the rat and spatial navigation: evidence for impaired planning. Behav Neurosci 109: 474-484
45. Granon S, Poucet B, Thinus-Blanc C, Changeux J-P, Vidal C (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology 119: 139-144
46. Harvey JA, Gormezano I, Cool-Hauser VA (1983) Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit nictitating membrane response. J Pharmacol Exp Ther 225: 42-49 (Pubitemid 13137001)
47. Hasselmo ME (1999) Neuromodulation: acetylcholine and memory consolidation. Trends Cogn Sci 3: 351-359 (Pubitemid 29417567)
48. Hasselmo ME (2006) The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16: 710-715 (Pubitemid 44791918)
49. Herremans AH, Hijzen TH (1997) The delayed-conditionaldiscrimination task improves measurement of working memory in rats. Neurosci Biobehav Rev 21: 371-379 (Pubitemid 27225157)
50. Herremans AHJ, Hijzen TH, Olivier B, Slangen JL (1995) Cholinergic drug effects on a delayed conditional discrimination task in the rat. Behav Neurosci 109: 426-435
51. Herremans AHJ, Hijzen TH, Welborn PFE, Olivier B, Slangen JL (1996) Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res 711: 102-111 (Pubitemid 26081842)
52. Herremans AHJ, Hijzen TH, Olivier B (1997) Effects of cholinergic drug infusions into the dorsal part of the medial prefrontal cortex on delayed conditional discrimination peformance in the rat. Behav Brain Res 84: 291-299 (Pubitemid 27112706)
53. Hodges DB Jr, Lindner MD, Hogan JB, Jones KM, Markus EJ (2009) Scopolamine induced deficits in a battery of rat cognitive tests: Comparisons of sensitivity and specificity. Behav Pharmacol 20: 237-251
54. Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134: 943-944
55. Hoff EI, van Oostenbrugge RJ, Liedenbaum M, Steinbusch HW, Blokland A (2007) Effects of right-hemisphere cortical infarction and muscarinic acetylcholine receptor blockade on spatial visual attention performance in rats. Behav Brain Res 178: 62-69 (Pubitemid 46240340)
56. Humby T, Laird FM, Davies W, Wilkinson LS (1999) Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 11: 2813-2823 (Pubitemid 29364198)
57. Jones SVP (1993) Muscarinic receptor subtypes: modulation of ion channels. Life Sci 52: 457-464
58. Jones CK, Shannon HE (2000) Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. J Pharmacol Exp Ther 294: 1017-1023 (Pubitemid 30666854)
59. Kamsler A, McHugh TJ, Gerber D, Huang SY, Tonegawa S (2010) Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus. Proc Natl Acad Sci USA 107: 1618-1623
60. Katayama S, Ishizaki F, Yamamura Y, Khoriyama T, Kito S (1990) Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain. Res Commun Chem Pathol 69: 261-270 (Pubitemid 20309692)
61. Kimura Y, Ohue M, Kitaura T, Kihira K (1999) Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor. Brain Res 834: 6-12 (Pubitemid 29332004)
62. Kirkby DL, Jones DNC, Higgins GA (1995) Influence of prefeeding and scopolamine upon performance in a delayed matching-toposition task. Behav Brain Res 67: 221-227
63. Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34: 1307-1350
64. Kramer-Soares JC, Vecchio-Fornari R, Menezes-Oliviera MG (2006) Role of muscarinic M1 receptors in inhibitory avoidance and contextual fear conditioning. Neurobiol Learn Mem 86: 188-196
65. Leaton RN, Kreindler M (1972) Effects of physostigmine and scopolamine on operant brightness discrimination in the rat. Physiol Behav 9: 121-123
66. Leblond L, Beaufort C, Delerue F, Durkin T (2002) Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice. Behav Brain Res 128: 91-102 (Pubitemid 34033638)
67. Liu W (1996) Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats. Pharmacol Biochem Behav 54: 425-430 (Pubitemid 26180180)
68. Liu L, Zhao R, Bai Y, Stanish LF, Evans JE, Sanderson MJ, Bonventre JV, Rittenhouse AR (2006) M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades. J Neurosci 26: 11588-11598 (Pubitemid 44772130)
69. Loiseau F, Dekeyne A, Millan MJ (2008) Pro-cognitive effects of 5HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology 196: 93-104
70. Ma L, Seager MA, Wittmann M, Jacobson M, Bickel D, Burno M, Jones K, Kuzmick-Graufelds V, Xu G, Pearson M, McCampbell A, Gaspar R, Shugrue P, Danziger A, Regan C, Flick R, Pascarella D, Garson S, Doran S, Kreatsoulas C, Veng L, Lindsey CW, Shipe W, Kuduk S, Sur C, Kinney G, Seabrook GR, Ray WJ (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. P Natl Acad Sci 106: 15950-15955
71. Marino MJ, Rouse ST, Levey AI, Potter LT, Conn PJ (1998) Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci USA 95: 11465-11470 (Pubitemid 28450152)
72. McCool MF, Patel S, Talati R, Ragozzino ME (2008) Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching. Neurobiol Learn Mem 89: 114-124 (Pubitemid 350235964)
73. McDonald MP, Willard LB, Wenk GL, Crawly JN (1998) Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. J Neurosci 18: 5078-5085 (Pubitemid 28285416)
74. Messer WS, Miller MD (1988) Intrahippocampal injections of gallamine impair learning of a memory task. Neurosci Lett 89: 367-372
75. Messer WS, Thomas GJ, Hoss W (1987) Selectivity of pirenzepine in the central nervous system. II differential effects of pirenzepine and scopolamine on performance of a representational memory task. Brain Res 407: 37-45 (Pubitemid 17049829)
76. Messer WS, Bohnett M, Stibbe J (1990) Evidence for a preferential involvement of M1 muscarinic receptors in representational memory. Neurosci Lett 116: 184-189 (Pubitemid 20237157)
77. Mirza NR, Stolerman IP (2000) The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology 148: 243-250 (Pubitemid 30136731)
78. Moore H, Dudchenko P, Comer KS, Bruno JP, Sarter M (1992) Central versus peripheral effects of muscarinic antagonists: the limitations of quarternary ammonium derivatives. Psychopharmacology 108: 241-243
79. Myers TM, Galbicka G, Sipos ML, Varadi S, Oubre JL, Clark MG (2002) Effects of anticholinergics on serial-probe recognition accuracy of rhesus macaques (Macaca mulatta). Pharmacol Biochem Behav 73: 829-834 (Pubitemid 35246231)
80. Myhrer T, Enger S, Aas P (2004) Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality. Eur J Pharmacol 483: 271-279 (Pubitemid 38068410)
81. Myhrer T, Enger S, Aas P (2008) Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats. Pharmacol Biochem Behav 89: 633-638
82. Nakashima E, Ishizaki F, Takeda M, Matsusushita R, Yokogawa K, Ichimura F (1993) Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats. Biopharm Drug Dispos 14: 673-684 (Pubitemid 23326730)
83. Ohno M, Yamamoto T, Watanabe S (1994) Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats. Brain Res 650: 260-266
84. Otto T, Eichenbaum H (1992) Complementary roles of orbital prefrontal cortex and the perirhinal-entorhinal cortices in an odor-guided delayed non-matchong to sample task. Behav Neurosci 106: 763-776
85. Ovsepian SV, Anwyl R, Rowan MJ (2004) Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. Eur J Neurosci 20: 1267-1275 (Pubitemid 39233579)
86. Pakarinen ED, Moerschbaecher JM (1993) Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys. Pharmacol Biochem Behav 44: 815-819
87. Phillips JM, McAlonan K, Robb WG, Brown VJ (2000) Cholinergic neurotransmission influences covert orientation of visuospatial attention in the rat. Psychopharmacology 150: 112-116 (Pubitemid 30350820)
88. Poulin B, Butcher A, McWilliams P, Bourgognon JM, Pawlak R, Kong KC, Bottrill A, Mistry S, Wess J, Rosethorne EM, Charlton SJ, Tobin AB (2010) The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestindependent manner. Proc Natl Acad Sci USA 107: 9440-9445
89. Power AE, McIntyre CK, Litmanovich A, McGaugh JL (2003) Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. Behav Pharmacol 14: 207-213 (Pubitemid 36735153)
90. Pradhan SN, Roth T (1968) Comparative behavioral effects of several anti-cholinergic agents in rats. Psychopharmacologia 12: 358-366
91. Pratt WE, Kelley AE (2004) Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behav Neurosci 118: 730-739 (Pubitemid 38970495)
92. Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102: 73-88 (Pubitemid 29314570)
93. Quirion R, Wilson A, Rowe W, Aubert I, Richard J, Doods H, White N, Meaney MJ (1995) Facilitation of acetylcholine release and cognitive performance by an M2-muscarinic receptor antagonist in aged memory-impaired rats. J Neurosci 15: 1455-1462
94. Robinson JK, Mao JB (1997) Differential effects on delayed nonmatching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus. Brain Res 765: 51-60 (Pubitemid 27374913)
95. Roldán G, Bolaňos-Badillo E, González-Sánchez H, Quirarte GL, Prado-Alcalá RA (1997) Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neurosci Lett 230: 93-96 (Pubitemid 27312391)
96. Rouse ST, Levey AI (1996) Expression of m1-m4 muscarinic acetylcholine receptor immunoreactivity in septohippocampal neurons and other identified hippocampal afferents. J Comp Neurol 375: 406-416 (Pubitemid 26374781)
97. Ruotsalainen S, Miettinen R, Macdonald E, Riekkinen M, Sirviö J (1998) The role of the dorsal raphe-serotonergic system and cholinergic receptors in the modulation of working memory. Neurosci Biobehav Rev 22: 21-31 (Pubitemid 28082282)
98. Santi A, Weise L (1995) The effects of scopolamine on memory for time in rats and pigeons. Pharmacol Biochem Behav 51: 271-277
99. Sarter M, Bruno JP (1997) Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23: 28-46 (Pubitemid 27090748)
100. Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, Sheardown MJ, Swedberg MDB, Suzdak PD, Sauerberg P (1994) Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther 269: 271-281 (Pubitemid 24143264)
101. Sheffler DJ, Williams R, Bridges TM, Xiang Z, Kane AS, Byun NE, Jadhav S, Mock MM, Zheng F, Lewis LM, Jones CK, Niswender CM, Weaver CD, Lindsley CW, Conn PJ (2009) A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol Pharmacol 76: 356-368
102. Shida T, Tokunaga A, Kondo E, Ueda Y, Ohno K, Saika T, Kiyama H, Tohyama M (1993) Expression of muscarinic and nicotinic receptor mRNA in the salivary gland of rats: a study by in situ hybridization histochemistry. Mol Brain Res 17: 335-339
103. Shinoe T, Matsui M, Taketo MM, Manabe T (2005) Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J Neurosci 25: 11194-11200 (Pubitemid 43089564)
104. Shiraishi K, Takayanagi I (1993) Subtype of muscarinic receptors mediating relaxation and contraction in the rat iris dilator smooth muscle. Gen Pharmacol 24: 139-142 (Pubitemid 23089188)
105. Sipos ML, Burchnell V, Galbicka G (1999) Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats. Psychopharmacology 147: 250-256 (Pubitemid 30010544)
106. Sipos ML, Burchnell V, Galbicka G (2001) Effects of selected anticholinergics on acoustic startle response in rats. J Appl Toxicol 21: S95-S101
107. Spinelli S, Ballard T, Feldon J, Higgins GA, Pryce CR (2006) Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys. Neuropharmacology 51: 238-250 (Pubitemid 44061881)
108. Stanhope KJ, McLenachan AP, Dourish CT (1995) Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology 122: 268-280
109. Steckler T (2001) Using signal detection methods for analysis of operant performance in mice. Behav Brain Res 125: 237-248 (Pubitemid 33000462)
110. Syvälahti EKG, Kunelios R, Laurén L (1988) Effects of antiparkinsonian drugs on muscarinic receptor binding in rat brain, heart and lung. Basic Clin Pharmacol Toxicol 62: 90-94 (Pubitemid 18046375)
111. Taffe MA, Weed MR, Gold LH (1999) Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Cognitive Brain Res 8: 203-212 (Pubitemid 29518307)
112. Tobin G, Giglio D, Götrick B (2002) Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci-Basic 100: 1-9
113. Tzavos A, Jih J, Ragozzino ME (2004) Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning. Behav Brain Res 154: 245-253 (Pubitemid 39070472)
114. Vaisman N, Pelled D (2009) n-3 phosphatidylserine attenuated scopolamine-induced amnesia in middle-aged rats. Prog Neuro-Psychoph 33: 952-959
115. van Haaren F, van Hest A (1989) The effects of scopolamine and methylscopolamine on visual and auditory discriminations in male and female Wistar rats. Pharmacol Biochem Behav 32: 707-710 (Pubitemid 19162392)
116. Volpicelli LA, Levey AI (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 145: 59-66 (Pubitemid 37442934)
117. Wall PM, Flinn J, Messier C (2001) Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. Psychopharmacology 155: 58-68 (Pubitemid 32295770)
118. Wess J (2004) Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol 44: 423-450 (Pubitemid 38263848)
119. Wezenberg E, Verkes RJ, Sabbe BG, Ruigt GS, Hulstijn W (2005) Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology 181: 582-594 (Pubitemid 41480908)
120. Yeomans J, Baptista M (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57: 915-921 (Pubitemid 27334444)
121. Yokogawa K, Nakashima E, Ichimura F (1990) Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats. Drug Metab Dispos 18: 258-263 (Pubitemid 20107725)
122. Yokogawa K, Nakashima E, Ishizaki J, Hasegawa M, Kido H, Ichimura F (1992) Brain regional pharmacokinetics of biperiden in rats. Biopharm Drug Dispos 13: 131-140